Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic vinca alkaloids vinorelbine and its newer derivative vinflunine

被引:134
作者
Ngan, VK
Bellman, K
Hill, BT
Wilson, L
Jordan, MA [1 ]
机构
[1] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA
[2] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA
[3] Ctr Rech Pierre Fabre, Div Cancerol Expt, F-81106 Castres, France
关键词
D O I
10.1124/mol.60.1.225
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The two second-generation Vinca alkaloids, vinorelbine and vinflunine, affect microtubule dynamics very differently from vinblastine, a first generation Vinca alkaloid. For example, vinblastine strongly suppresses the rate and extent of microtubule shortening in vitro, whereas vinorelbine and vinflunine suppress the rate and extent of microtubule growing events. We asked whether these differences result in differences in mitotic spindle organization that might be responsible for the superior antitumor activities of the two second-generation Vinca alkaloids. IC50 values for inhibition of HeLa cell proliferation for vinflunine, vinorelbine, and vinblastine were 18, 1.25, and 0.45 nM, respectively, similar to the concentrations that induced mitotic block at the metaphase/anaphase transition (38, 3.8, and 1.1 nM, respectively), indicating that mitotic block is a major contributor to antiproliferative action for all three drugs. Mitotically blocked cells exhibited aberrant spindles, consistent with induction of block by suppression of microtubule dynamics. Despite differences in their actions on individual dynamic instability parameters, morphologically detectable differences in spindle effects among the three drugs were minimal, indicating that overall suppression of dynamics may be more important in blocking mitosis than specific effects on growth or shortening. We also found that the peak intracellular drug concentration at the mitotic IC50 value was highest for vinflunine (4.2 +/- 0.2 muM), intermediate for vinorelbine (1.3 +/- 0.1 muM), and more than 10-fold lower for vinblastine (130 +/- 7 nM), suggesting that intracellular binding reservoir(s) may be partially responsible for vinflunine's high efficacy and minimal side effects.
引用
收藏
页码:225 / 232
页数:8
相关论文
共 37 条
[1]  
Armand Jean-Pierre, 2001, Proceedings of the American Association for Cancer Research Annual Meeting, V42, P381
[2]   IMMUNOFLUORESCENCE STUDY OF THE ACTION OF NAVELBINE, VINCRISTINE AND VINBLASTINE ON MITOTIC AND AXONAL MICROTUBULES [J].
BINET, S ;
CHAINEAU, E ;
FELLOUS, A ;
LATASTE, H ;
KRIKORIAN, A ;
COUZINIER, JP ;
MEININGER, V .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (02) :262-266
[3]  
Bunn PA, 1998, CLIN CANCER RES, V4, P1087
[5]   VINBLASTINE SUPPRESSES DYNAMICS OF INDIVIDUAL MICROTUBULES IN LIVING INTERPHASE CELLS [J].
DHAMODHARAN, R ;
JORDAN, MA ;
THROWER, D ;
WILSON, L ;
WADSWORTH, P .
MOLECULAR BIOLOGY OF THE CELL, 1995, 6 (09) :1215-1229
[6]  
DONEHOWER RC, 1993, CANC PRINCIPLES PRAC, P409
[7]   Vinca alkaloids in superacidic media: A method for creating a new family of antitumor derivatives [J].
Fahy, J ;
Duflos, A ;
Ribet, JP ;
Jacquesy, JC ;
Berrier, C ;
Jouannetaud, MP ;
Zunino, F .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (36) :8576-8577
[8]  
Fumoleau P., 2001, Proceedings of the American Association for Cancer Research Annual Meeting, V42, P834
[9]   POLEWARD FORCE AT THE KINETOCHORE IN METAPHASE DEPENDS ON THE NUMBER OF KINETOCHORE MICROTUBULES [J].
HAYS, TS ;
SALMON, ED .
JOURNAL OF CELL BIOLOGY, 1990, 110 (02) :391-404
[10]   Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts [J].
Hill, BT ;
Fiebig, HH ;
Waud, WR ;
Poupon, MF ;
Colpaert, F ;
Kruczynski, A .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (03) :512-520